Request appointment
1275 York AvenueNew York, NY 10065
Overview of Dr. Kramer
Dr. Kim Kramer is a pediatric hematologist/oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center, NYC Health + Hospitals / Bellevue, and New York-Presbyterian Hospital. She received her medical degree from SUNY Upstate Medical University and has been in practice 37 years. She is one of 107 doctors at Memorial Sloan Kettering Cancer Center and one of 14 doctors at NYC Health + Hospitals / Bellevue who specialize in Pediatric Hematology & Oncology. She has more than 100 publications and over 500 citings.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 1993 - 1996
University of Rochester Medical CenterFellowship, Pediatric Hematology/Oncology, 1992 - 1993- University of Rochester Medical CenterResidency, Pediatrics, 1989 - 1992
SUNY Upstate Medical UniversityClass of 1989
Certifications & Licensure
NY State Medical License 1993 - 2028
NC State Medical License 2021 - 2022
American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer
- Radiolabeled MAB Therapy in Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer Start of enrollment: 2004 Feb 05
- Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
Publications & Presentations
PubMed
- Naxitamab with novel scheduling and stepped-up dosing of GM-CSF plus vaccine, but no myeloablative therapy for patients with high-risk neuroblastoma in first complete ...Brian H Kushner, Charlie White, Audrey Mauguen, Fiorella Iglesias Cardenas, Ellen M Basu
International Journal of Cancer. 2026-06-01 - 1 citationsRapid COJEC without myeloablative therapy for high-risk neuroblastoma.Brian H Kushner, Ellen M Basu, Fiorella Iglesias Cardenas, Kim Kramer, Shakeel Modak
International Journal of Cancer. 2025-12-15 - 9 citationsPhase 1 dose-escalation trial using convection-enhanced delivery of radio-immunotheranostic 124I-Omburtamab for diffuse intrinsic pontine glioma.Mark M Souweidane, Evan D Bander, Pat Zanzonico, Anne S Reiner, Nicole Manino
Neuro-Oncology. 2025-09-17
Press Mentions
- Y-mAbs Announces Update on Naxitamab and Omburtamab in NeuroblastomaOctober 16th, 2020
Y-mAbs Announces Positive Omburtamab Clinical DataOctober 28th, 2019
Finding a Cure for Children with CNS NeuroblastomaJuly 22nd, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
